Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ANTHEM BIOSCIENCES LTD.

NSE : ANTHEMBSE : 544449ISIN CODE : INE0CZ201020Industry : Pharmaceuticals & DrugsHouse : Private

BSE681.2035.15 (+5.44 %)

PREV CLOSE ( ) 646.05

OPEN PRICE ( ) 637.30

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 63766

TODAY'S LOW / HIGH ( )632.55 690.00

52 WK LOW / HIGH ( )579.45 873.25

NSE681.4535.6 (+5.51 %)

PREV CLOSE( ) 645.85

OPEN PRICE ( ) 640.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 681.45 (2097)

VOLUME 996571

TODAY'S LOW / HIGH( ) 633.00 690.45

52 WK LOW / HIGH ( )579.15 873.5

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-06 2006

Management Info

Ajay Bhardwaj - Chairman Ajay Bhardwaj - Managing Director

Registered Office

Address No. 49, F1 & F2, Canara Bank Road,Bommasandra Industrial Area,Phase I, Bommasandra,
Bengaluru,
Karnataka-560099

Phone 080-66724000

Email investors.abl@anthembio.com

Website www.anthembio.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

07Jan Anthem Biosciences informs about updates
Anthem Biosciences has informed regarding issuance of Corporate Guarante..

15Dec Anthem Biosciences informs about inves
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure..

29Sep Anthem Biosciences informs about tradi
Anthem Biosciences has informed that the Trading Window for dealing in s..

14Aug Anthem Biosciences reports 65% jump in
Anthem Biosciences has reported result for first quarter ended June 30,..

14Aug Anthem Biosciences trades jubilantly o
Anthem Biosciences is currently trading at Rs. 824.00, up by 69.30 point..

Financials

Rs. in Millions

	QTR Dec 25	ANNUAL
Net Profit	1121.26
Gross Profit	1501.1
Operating Profit	2029.69
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Onesource Specialty (BSE) 1452.15 (6.99%)	M.Cap ( in Cr)16644.72
Emcure Pharma (BSE) 1653.60 (3.75%)	M.Cap ( in Cr)31350.53
Mankind Pharma (BSE) 2040.25 (0.99%)	M.Cap ( in Cr)84227.30
Gland Pharma (BSE) 1728.75 (1.16%)	M.Cap ( in Cr)28482.27
Acutaas Chemicals (BSE) 2544.35 (0.75%)	M.Cap ( in Cr)20830.88

Shareholding Pattern

	PROMOTERS	74.69%
	NON-INSTITUTION	16.35%
	MUTUAL FUNDS/UTI	6.89%
	FI/BANKS/INSURANCE	0.44%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

ANTHEM BIOSCIENCES LTD.